GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Cyclically Adjusted Price-to-FCF

Cresco Labs (XCNQ:CL) Cyclically Adjusted Price-to-FCF : (As of May. 20, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Cresco Labs's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Cyclically Adjusted Price-to-FCF Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cresco Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cresco Labs's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted Price-to-FCF falls into.



Cresco Labs Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Cresco Labs's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cresco Labs's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.119/131.7762*131.7762
=0.119

Current CPI (Mar. 2024) = 131.7762.

Cresco Labs Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 0.000 100.023 0.000
201407 -0.143 100.520 -0.187
201410 0.000 100.176 0.000
201501 -1.286 98.604 -1.719
201504 0.000 99.824 0.000
201507 0.000 100.691 0.000
201510 0.000 100.346 0.000
201601 3.400 99.957 4.482
201604 0.000 100.947 0.000
201607 0.000 101.524 0.000
201610 0.000 101.988 0.000
201701 -0.857 102.456 -1.102
201704 -2.686 103.167 -3.431
201707 -0.257 103.278 -0.328
201710 0.086 104.070 0.109
201801 3.743 104.578 4.716
201804 0.000 105.708 0.000
201807 0.000 106.324 0.000
201810 -12.844 106.695 -15.863
201903 -0.221 107.251 -0.272
201906 -0.272 108.070 -0.332
201909 -0.351 108.329 -0.427
201912 -0.490 108.420 -0.596
202003 -0.580 108.902 -0.702
202006 -0.161 108.767 -0.195
202009 0.024 109.815 0.029
202012 0.017 109.897 0.020
202103 -0.052 111.754 -0.061
202106 -0.344 114.631 -0.395
202109 -0.090 115.734 -0.102
202112 0.090 117.630 0.101
202203 -0.177 121.301 -0.192
202206 -0.092 125.017 -0.097
202209 0.020 125.227 0.021
202212 -0.044 125.222 -0.046
202303 -0.080 127.348 -0.083
202306 -0.001 128.729 -0.001
202309 0.109 129.860 0.111
202312 -0.034 129.419 -0.035
202403 0.119 131.776 0.119

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cresco Labs  (XCNQ:CL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Cresco Labs Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (XCNQ:CL) Business Description

Industry
Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.